Shares of Shilpa Medicare Ltd were trading in the green and almost 2% higher on 12 October after the company announced that it has received European Good Manufacturing Practice (GMP) certification for its Unit 4 facility in Jadcherla, Telangana, strengthening its ability to supply pharmaceutical products to European and other...
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.